Moreover, one patient of CD5-positive DLBCL with testicular involvement also achieved CR, suggesting that anti-CD19 and anti-CD20 CAR-T cells are capable of passing the blood–testis barrier [51]. Here, CD19 is linked to diffuse large B-cell lymphoma.